Guselkumab for the Treatment of Patients with Moderate-to-severe Hidradenitis Suppurativa: A Phase 2 Randomized Study.
Journal of the European Academy of Dermatology and Venereology : JEADV（2023）
摘要
gov: NCT03628924.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要